6Wu SS, Xia YY, Lv XZ, et al. Effect of scheduled monitoring of liver function during anti tuberculosis treatment in a retrospec- tive cohort in China. BMC Public Health, 2012, (12) ;454.
7高微微,李琦,高孟秋,等.特殊人群结核病防治.北京:科学出版社,2011:19.
8Shang PH, Xia YY, Liu FY, et al. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China. PLoS One, 2011, 6(7) :e21836.
9Xia YY, Hu DY, Liu FY, et al. Design of the anti-tuberculo- sis drugs induced adverse reactions in China National Tubercu- losis Prevention and Control Scheme Study (ADACS). BMC Public Health, 2010, (10) :267.
10Tostmann A, Boeree MJ, Aarnoutse RE, et al. Antitubercu- losis drug-induced hepatotoxicity Concise up-to-date review. J Gastroenterol Hepatol, 2008, 23(2):192-202.
